mrna Search Results


99
New England Biolabs ivt
Ivt, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna/pm40335671-175-0-9?v=New+England+Biolabs
Average 99 stars, based on 1 article reviews
ivt - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

94
Miltenyi Biotec stemmacs egfp mrna
List of RT qPCR primers.
Stemmacs Egfp Mrna, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna/pmc11613969-58-32-36?v=Miltenyi+Biotec
Average 94 stars, based on 1 article reviews
stemmacs egfp mrna - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

86
Gedeon Richter mrna
List of RT qPCR primers.
Mrna, supplied by Gedeon Richter, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna/10__1016_slash_j__stress__2024__100497-309-4-46?v=Gedeon+Richter
Average 86 stars, based on 1 article reviews
mrna - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Moderna sanofi mrna 1011
List of RT qPCR primers.
Sanofi Mrna 1011, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna/pm41710955-64-146-148?v=Moderna
Average 86 stars, based on 1 article reviews
sanofi mrna 1011 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

96
Roche kapa stranded mrna seq kit
List of RT qPCR primers.
Kapa Stranded Mrna Seq Kit, supplied by Roche, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna/pm27838340-260-14-18?v=Roche
Average 96 stars, based on 1 article reviews
kapa stranded mrna seq kit - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

94
Proteintech dcp1a1 350 proteintech
List of RT qPCR primers.
Dcp1a1 350 Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna/pmc11447053__42003_2024_6900_MOESM2_ESM-50-122-123?v=Proteintech
Average 94 stars, based on 1 article reviews
dcp1a1 350 proteintech - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

92
Rockland Immunochemicals rabbit anti collagen vi
List of RT qPCR primers.
Rabbit Anti Collagen Vi, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna/pmc05925812-345-98-105?v=Rockland+Immunochemicals
Average 92 stars, based on 1 article reviews
rabbit anti collagen vi - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

94
Qiagen turbocapture 384 mrna kit
List of RT qPCR primers.
Turbocapture 384 Mrna Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna/pmc07553155-182-15-19?v=Qiagen
Average 94 stars, based on 1 article reviews
turbocapture 384 mrna kit - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

99
Illumina Inc truseq stranded mrna sample preparation kit
Osteo-angiogenic development of long bones is disrupted in VEGF cTg mice (A) Total VEGF <t>mRNA</t> (qRT-PCR) and VEGF 164 protein levels (ELISA) in bones of control and VEGF cTg embryos (n = 4–8). (B) VEGF serum levels (ELISA) (n = 6). (C) Skeletal preparations at E18.5. Middle panels, dissected hindlimbs of control (top) and VEGF cTg (bottom). (D) Longitudinal (top) and transversal (bottom) 3D micro-computed tomography (micro-CT) reconstructions of E18.5 tibias. (E) Histology of E18.5 tibias; (left) Safranin O and (right) H&E. Brackets, BM cavity. (F) BM cavity volume at E18.5 (n = 7). (G) CD31 IHC on tibia sections. Arrows, aberrant perichondrial vascularization. (H) Maximum intensity projection (MIP) of 20-μm depth confocal imaging of Osx-Cre:GFP (nuclear green, OPCs), Emcn (red, blood vessels), and Hoechst (blue, nuclei) in E18.5 tibias. Left, overview; middle, metaphysis; right, diaphysis. (I) Flow cytometry of CD45 − Ter119 − CD31 − Osx/GFP + cells in E18.5 bones (n = 4–5). All graphs represent mean ± SEM and depict individual data points derived from different mice (also in the next figures); ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, by Student’s t test between the genotypes for each time point; no symbol implies p > 0.05. See also <xref ref-type=Figure S1 . " width="250" height="auto" />
Truseq Stranded Mrna Sample Preparation Kit, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna/pmc08411121-475-15-21?v=Illumina+Inc
Average 99 stars, based on 1 article reviews
truseq stranded mrna sample preparation kit - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

94
Miltenyi Biotec multimacs mrna isolation kit
a, A screenshot of a representative sequence trace file of a CRISPR-generated TMEM30A frameshift mutation in exon 1 (DOHH-2, MUT1). b, TMEM30A <t>mRNA</t> expression is reduced in 3 unique bi-allelic frame-shift mutations in Karpas422, compared with parental and single cell enriched controls. mRNA expression is normalized to GAPDH expression. Graphs represent mean values ± s.d. (n = 3). (c) mRNA expression of TMEM30A is ‘rescued’ in one unique bi-allelic TMEM30A mutant, by ectopically expressing a stable insertion of a TMEM30A cDNA. Graphs represent mean values ± s.d. (n = 3). d, mRNA levels of different scramblases (PLSCR1-5; ANO1-10, XKR1-9), flippases (TMEM30A-C) and P4-ATPases in Karpas422 (left panel) and NUDUL-1 (right panel) native (WT, CON) and TMEM30A−/− (MUT) cell lines. Protein family members are categorized, and the heat map values show log-normalized expression by RNA-seq. e, XKR8 and ANO6 mRNA expression is reduced in 3 unique bi-allelic (XKR8) and mono-allelic (ANO6) frame-shift mutations in TMEM30A−/− and wildtype controls. mRNA expression is normalized to GAPDH expression. Graphs represent mean values ± s.d. (n = 3). All P values are based on a paired two-tailed Student’s t test.
Multimacs Mrna Isolation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna/pmc08480332-557-8-17?v=Miltenyi+Biotec
Average 94 stars, based on 1 article reviews
multimacs mrna isolation kit - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

97
New England Biolabs magnetic mrna isolation kit
a, A screenshot of a representative sequence trace file of a CRISPR-generated TMEM30A frameshift mutation in exon 1 (DOHH-2, MUT1). b, TMEM30A <t>mRNA</t> expression is reduced in 3 unique bi-allelic frame-shift mutations in Karpas422, compared with parental and single cell enriched controls. mRNA expression is normalized to GAPDH expression. Graphs represent mean values ± s.d. (n = 3). (c) mRNA expression of TMEM30A is ‘rescued’ in one unique bi-allelic TMEM30A mutant, by ectopically expressing a stable insertion of a TMEM30A cDNA. Graphs represent mean values ± s.d. (n = 3). d, mRNA levels of different scramblases (PLSCR1-5; ANO1-10, XKR1-9), flippases (TMEM30A-C) and P4-ATPases in Karpas422 (left panel) and NUDUL-1 (right panel) native (WT, CON) and TMEM30A−/− (MUT) cell lines. Protein family members are categorized, and the heat map values show log-normalized expression by RNA-seq. e, XKR8 and ANO6 mRNA expression is reduced in 3 unique bi-allelic (XKR8) and mono-allelic (ANO6) frame-shift mutations in TMEM30A−/− and wildtype controls. mRNA expression is normalized to GAPDH expression. Graphs represent mean values ± s.d. (n = 3). All P values are based on a paired two-tailed Student’s t test.
Magnetic Mrna Isolation Kit, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna/bio_rxiv__64898__2026__05__04__722827-258-13-12?v=New+England+Biolabs
Average 97 stars, based on 1 article reviews
magnetic mrna isolation kit - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier

99
New England Biolabs nebnext poly a mrna magnetic isolation module
a, A screenshot of a representative sequence trace file of a CRISPR-generated TMEM30A frameshift mutation in exon 1 (DOHH-2, MUT1). b, TMEM30A <t>mRNA</t> expression is reduced in 3 unique bi-allelic frame-shift mutations in Karpas422, compared with parental and single cell enriched controls. mRNA expression is normalized to GAPDH expression. Graphs represent mean values ± s.d. (n = 3). (c) mRNA expression of TMEM30A is ‘rescued’ in one unique bi-allelic TMEM30A mutant, by ectopically expressing a stable insertion of a TMEM30A cDNA. Graphs represent mean values ± s.d. (n = 3). d, mRNA levels of different scramblases (PLSCR1-5; ANO1-10, XKR1-9), flippases (TMEM30A-C) and P4-ATPases in Karpas422 (left panel) and NUDUL-1 (right panel) native (WT, CON) and TMEM30A−/− (MUT) cell lines. Protein family members are categorized, and the heat map values show log-normalized expression by RNA-seq. e, XKR8 and ANO6 mRNA expression is reduced in 3 unique bi-allelic (XKR8) and mono-allelic (ANO6) frame-shift mutations in TMEM30A−/− and wildtype controls. mRNA expression is normalized to GAPDH expression. Graphs represent mean values ± s.d. (n = 3). All P values are based on a paired two-tailed Student’s t test.
Nebnext Poly A Mrna Magnetic Isolation Module, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrna/10__1016_slash_j__neuron__2026__01__018-445-18-24?v=New+England+Biolabs
Average 99 stars, based on 1 article reviews
nebnext poly a mrna magnetic isolation module - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

Image Search Results


List of RT qPCR primers.

Journal: The FASEB Journal

Article Title: Purification of mitochondria from skeletal muscle tissue for transcriptomic analyses reveals localization of nuclear‐encoded noncoding RNAs

doi: 10.1096/fj.202401618R

Figure Lengend Snippet: List of RT qPCR primers.

Article Snippet: RNase treatment: To remove RNA not localized within intact mitochondria, in a 50 μL reaction, aliquots of isolated mitochondria (1 μg total protein each) first had 100 ng mRNA spike‐in control added (StemMACS eGFP mRNA #130‐101‐114, Miltenyi Biotec) and were then incubated with or without Triton X‐100 (1% v/v) and with or without RNase‐A (Qiagen #19101, final concentration range 1–1000 μg/mL) and incubated on ice for 30 min. TRIzol reagent was then added to simultaneously inactivate RNase activity, lyse mitochondria, and preserve RNA.

Techniques: Quantitative RT-PCR

RNase‐A treatment of mitochondria isolated from L6 myocytes. Isolated mitochondria were incubated with or without RNase‐A (1–1000 μg/mL) in the presence or absence of detergent (1% Triton X‐100). The levels of representative (A) mtDNA ( Mt‐co3 )‐ and (B) nuclear ( Cox4i1 )‐encoded genes were then assessed by RT‐qPCR in addition to (C) an exogenous mRNA spike‐in control ( eGFP ) added to isolated mitochondria (but not to the whole cell lysate). The values were derived by exponential transformation of the C q value, and data for each gene are expressed as a fraction of the untreated isolated mitochondria condition (relative expression). Data are mean (SD) for N = 3 technical replicates from a single mitochondrial isolation preparation.

Journal: The FASEB Journal

Article Title: Purification of mitochondria from skeletal muscle tissue for transcriptomic analyses reveals localization of nuclear‐encoded noncoding RNAs

doi: 10.1096/fj.202401618R

Figure Lengend Snippet: RNase‐A treatment of mitochondria isolated from L6 myocytes. Isolated mitochondria were incubated with or without RNase‐A (1–1000 μg/mL) in the presence or absence of detergent (1% Triton X‐100). The levels of representative (A) mtDNA ( Mt‐co3 )‐ and (B) nuclear ( Cox4i1 )‐encoded genes were then assessed by RT‐qPCR in addition to (C) an exogenous mRNA spike‐in control ( eGFP ) added to isolated mitochondria (but not to the whole cell lysate). The values were derived by exponential transformation of the C q value, and data for each gene are expressed as a fraction of the untreated isolated mitochondria condition (relative expression). Data are mean (SD) for N = 3 technical replicates from a single mitochondrial isolation preparation.

Article Snippet: RNase treatment: To remove RNA not localized within intact mitochondria, in a 50 μL reaction, aliquots of isolated mitochondria (1 μg total protein each) first had 100 ng mRNA spike‐in control added (StemMACS eGFP mRNA #130‐101‐114, Miltenyi Biotec) and were then incubated with or without Triton X‐100 (1% v/v) and with or without RNase‐A (Qiagen #19101, final concentration range 1–1000 μg/mL) and incubated on ice for 30 min. TRIzol reagent was then added to simultaneously inactivate RNase activity, lyse mitochondria, and preserve RNA.

Techniques: Isolation, Incubation, Quantitative RT-PCR, Control, Derivative Assay, Transformation Assay, Expressing

Osteo-angiogenic development of long bones is disrupted in VEGF cTg mice (A) Total VEGF mRNA (qRT-PCR) and VEGF 164 protein levels (ELISA) in bones of control and VEGF cTg embryos (n = 4–8). (B) VEGF serum levels (ELISA) (n = 6). (C) Skeletal preparations at E18.5. Middle panels, dissected hindlimbs of control (top) and VEGF cTg (bottom). (D) Longitudinal (top) and transversal (bottom) 3D micro-computed tomography (micro-CT) reconstructions of E18.5 tibias. (E) Histology of E18.5 tibias; (left) Safranin O and (right) H&E. Brackets, BM cavity. (F) BM cavity volume at E18.5 (n = 7). (G) CD31 IHC on tibia sections. Arrows, aberrant perichondrial vascularization. (H) Maximum intensity projection (MIP) of 20-μm depth confocal imaging of Osx-Cre:GFP (nuclear green, OPCs), Emcn (red, blood vessels), and Hoechst (blue, nuclei) in E18.5 tibias. Left, overview; middle, metaphysis; right, diaphysis. (I) Flow cytometry of CD45 − Ter119 − CD31 − Osx/GFP + cells in E18.5 bones (n = 4–5). All graphs represent mean ± SEM and depict individual data points derived from different mice (also in the next figures); ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, by Student’s t test between the genotypes for each time point; no symbol implies p > 0.05. See also <xref ref-type=Figure S1 . " width="100%" height="100%">

Journal: Cell Reports

Article Title: Fetal hematopoietic stem cell homing is controlled by VEGF regulating the integrity and oxidative status of the stromal-vascular bone marrow niches

doi: 10.1016/j.celrep.2021.109618

Figure Lengend Snippet: Osteo-angiogenic development of long bones is disrupted in VEGF cTg mice (A) Total VEGF mRNA (qRT-PCR) and VEGF 164 protein levels (ELISA) in bones of control and VEGF cTg embryos (n = 4–8). (B) VEGF serum levels (ELISA) (n = 6). (C) Skeletal preparations at E18.5. Middle panels, dissected hindlimbs of control (top) and VEGF cTg (bottom). (D) Longitudinal (top) and transversal (bottom) 3D micro-computed tomography (micro-CT) reconstructions of E18.5 tibias. (E) Histology of E18.5 tibias; (left) Safranin O and (right) H&E. Brackets, BM cavity. (F) BM cavity volume at E18.5 (n = 7). (G) CD31 IHC on tibia sections. Arrows, aberrant perichondrial vascularization. (H) Maximum intensity projection (MIP) of 20-μm depth confocal imaging of Osx-Cre:GFP (nuclear green, OPCs), Emcn (red, blood vessels), and Hoechst (blue, nuclei) in E18.5 tibias. Left, overview; middle, metaphysis; right, diaphysis. (I) Flow cytometry of CD45 − Ter119 − CD31 − Osx/GFP + cells in E18.5 bones (n = 4–5). All graphs represent mean ± SEM and depict individual data points derived from different mice (also in the next figures); ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, by Student’s t test between the genotypes for each time point; no symbol implies p > 0.05. See also Figure S1 .

Article Snippet: The extraction of total RNA (RNeasy Micro kit, QIAGEN), library preparation using 100 ng RNA (TruSeq Stranded mRNA Sample Preparation Kit, Illumina), indexing, quantification, validation of library quality and size range (DNA 1000 kit, Agilent Technologies), sequencing Illumina HiSeq2500, generating 50 bp single-end reads with a depth of 30-40 Mb per sample), and processing of results and bioinformatics was all done according to the procedures described before ( ).

Techniques: Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Control, Micro-CT, Imaging, Flow Cytometry, Derivative Assay

Delayed-onset VEGF overexpression in developing bones creates a hypomorph model of osteo-angiogenic alterations with a normal-size BM cavity (A) Total VEGF mRNA and VEGF 164 protein levels at E18.5 and P2 (n = 6–11). (B) VEGF serum levels at E18.5 (n = 6). (C) E18.5 skeletal preparations; bottom, hindlimbs. (D) H&E and BM cavity length of E18.5 tibias (n = 3). (E–G) Micro-CT of E18.5 tibias with (F) bone volume/tissue volume (BV/TV) and (G) BM cavity volume (n = 5). (H and I) CD31 IHC and (I) histomorphometry on E18.5 tibias. BLV, blood vessel (n = 3–4). (J) MIP (15-μm depth) of Osx--Cre:GFP, Emcn, and Hoechst signals in P2 tibias. (K) Flow cytometry of CD45 − Ter119 − CD31 − Osx-Cre:GFP + cells in P2 limbs (n = 7). (L and M) LSK, LSK-SLAM, and CD45 + cell counts in (L) bones and (M) spleens (n = 3–8). Graphs, mean ± SEM; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, t test. See also <xref ref-type=Figure S3 . " width="100%" height="100%">

Journal: Cell Reports

Article Title: Fetal hematopoietic stem cell homing is controlled by VEGF regulating the integrity and oxidative status of the stromal-vascular bone marrow niches

doi: 10.1016/j.celrep.2021.109618

Figure Lengend Snippet: Delayed-onset VEGF overexpression in developing bones creates a hypomorph model of osteo-angiogenic alterations with a normal-size BM cavity (A) Total VEGF mRNA and VEGF 164 protein levels at E18.5 and P2 (n = 6–11). (B) VEGF serum levels at E18.5 (n = 6). (C) E18.5 skeletal preparations; bottom, hindlimbs. (D) H&E and BM cavity length of E18.5 tibias (n = 3). (E–G) Micro-CT of E18.5 tibias with (F) bone volume/tissue volume (BV/TV) and (G) BM cavity volume (n = 5). (H and I) CD31 IHC and (I) histomorphometry on E18.5 tibias. BLV, blood vessel (n = 3–4). (J) MIP (15-μm depth) of Osx--Cre:GFP, Emcn, and Hoechst signals in P2 tibias. (K) Flow cytometry of CD45 − Ter119 − CD31 − Osx-Cre:GFP + cells in P2 limbs (n = 7). (L and M) LSK, LSK-SLAM, and CD45 + cell counts in (L) bones and (M) spleens (n = 3–8). Graphs, mean ± SEM; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, t test. See also Figure S3 .

Article Snippet: The extraction of total RNA (RNeasy Micro kit, QIAGEN), library preparation using 100 ng RNA (TruSeq Stranded mRNA Sample Preparation Kit, Illumina), indexing, quantification, validation of library quality and size range (DNA 1000 kit, Agilent Technologies), sequencing Illumina HiSeq2500, generating 50 bp single-end reads with a depth of 30-40 Mb per sample), and processing of results and bioinformatics was all done according to the procedures described before ( ).

Techniques: Over Expression, Micro-CT, Flow Cytometry

Journal: Cell Reports

Article Title: Fetal hematopoietic stem cell homing is controlled by VEGF regulating the integrity and oxidative status of the stromal-vascular bone marrow niches

doi: 10.1016/j.celrep.2021.109618

Figure Lengend Snippet:

Article Snippet: The extraction of total RNA (RNeasy Micro kit, QIAGEN), library preparation using 100 ng RNA (TruSeq Stranded mRNA Sample Preparation Kit, Illumina), indexing, quantification, validation of library quality and size range (DNA 1000 kit, Agilent Technologies), sequencing Illumina HiSeq2500, generating 50 bp single-end reads with a depth of 30-40 Mb per sample), and processing of results and bioinformatics was all done according to the procedures described before ( ).

Techniques: Flow Cytometry, Immunohistochemistry, Recombinant, Staining, Extraction, Modification, Electron Microscopy, Protease Inhibitor, SYBR Green Assay, Enzyme-linked Immunosorbent Assay, Purification, Reverse Transcription, RNA Sequencing, Control, Software

a, A screenshot of a representative sequence trace file of a CRISPR-generated TMEM30A frameshift mutation in exon 1 (DOHH-2, MUT1). b, TMEM30A mRNA expression is reduced in 3 unique bi-allelic frame-shift mutations in Karpas422, compared with parental and single cell enriched controls. mRNA expression is normalized to GAPDH expression. Graphs represent mean values ± s.d. (n = 3). (c) mRNA expression of TMEM30A is ‘rescued’ in one unique bi-allelic TMEM30A mutant, by ectopically expressing a stable insertion of a TMEM30A cDNA. Graphs represent mean values ± s.d. (n = 3). d, mRNA levels of different scramblases (PLSCR1-5; ANO1-10, XKR1-9), flippases (TMEM30A-C) and P4-ATPases in Karpas422 (left panel) and NUDUL-1 (right panel) native (WT, CON) and TMEM30A−/− (MUT) cell lines. Protein family members are categorized, and the heat map values show log-normalized expression by RNA-seq. e, XKR8 and ANO6 mRNA expression is reduced in 3 unique bi-allelic (XKR8) and mono-allelic (ANO6) frame-shift mutations in TMEM30A−/− and wildtype controls. mRNA expression is normalized to GAPDH expression. Graphs represent mean values ± s.d. (n = 3). All P values are based on a paired two-tailed Student’s t test.

Journal: Nature medicine

Article Title: TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma

doi: 10.1038/s41591-020-0757-z

Figure Lengend Snippet: a, A screenshot of a representative sequence trace file of a CRISPR-generated TMEM30A frameshift mutation in exon 1 (DOHH-2, MUT1). b, TMEM30A mRNA expression is reduced in 3 unique bi-allelic frame-shift mutations in Karpas422, compared with parental and single cell enriched controls. mRNA expression is normalized to GAPDH expression. Graphs represent mean values ± s.d. (n = 3). (c) mRNA expression of TMEM30A is ‘rescued’ in one unique bi-allelic TMEM30A mutant, by ectopically expressing a stable insertion of a TMEM30A cDNA. Graphs represent mean values ± s.d. (n = 3). d, mRNA levels of different scramblases (PLSCR1-5; ANO1-10, XKR1-9), flippases (TMEM30A-C) and P4-ATPases in Karpas422 (left panel) and NUDUL-1 (right panel) native (WT, CON) and TMEM30A−/− (MUT) cell lines. Protein family members are categorized, and the heat map values show log-normalized expression by RNA-seq. e, XKR8 and ANO6 mRNA expression is reduced in 3 unique bi-allelic (XKR8) and mono-allelic (ANO6) frame-shift mutations in TMEM30A−/− and wildtype controls. mRNA expression is normalized to GAPDH expression. Graphs represent mean values ± s.d. (n = 3). All P values are based on a paired two-tailed Student’s t test.

Article Snippet: Polyadenylated (polyA+) mRNA was purified using the 96-well MultiMACS mRNA isolation kit on the MultiMACS 96 separator (Miltenyi Biotec) then ethanol-precipitated, and used to synthesize complementary DNA using the Maxima H Minus First Strand cDNA Synthesis kit (Thermo-Fisher) and random hexamer primers at a concentration of 5 μM along with a final concentration of 1 μg μl −1 Actinomycin D, followed by Ampure XP SPRI bead purification on a Biomek FX robot (Beckman-Coulter).

Techniques: Expressing, In Vitro, Knock-Out, Sequencing, CRISPR, Generated, Mutagenesis, RNA Sequencing, Two Tailed Test